Active Ingredient: DABRAFENIB MESYLATE
Proprietary Name: TAFINLAR
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 75MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N202806
Product Number: 002
Approval Date: May 29, 2013
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Prescription
Patent and Exclusivity Information
